, indicating that ouabain produced positive inotropy in the absence of functional Na-Ca exchange and Na ϩ -K ϩ -ATPase activity. In contrast, ouabain had no inotropic response in rat ventricular myocytes (10-100 mol/l). Finally, ouabain reversibly increased Ca 2ϩ overload toxicity by accelerating the rate of spontaneous aftercontractions (n ϭ 13). These results suggest that the cellular effects of ouabain on the heart may include actions independent of Na ϩ -K ϩ -ATPase inhibition, Na-Ca exchange, and changes in Na i ϩ .
N-methyl-D-glucamine; cardiac glycosides; sarcoplasmic reticulum; digitalis toxicity CARDIAC GLYCOSIDES ARE WIDELY used clinically to treat congestive heart failure. The inotropic effect of cardiac steroids is thought to result from Na ϩ -K ϩ -ATPase inhibition (14, 17) . Cardiac steroids cause an increase in intracellular calcium (Ca i 2ϩ ) when applied to cardiac muscle (6, 39) . The mechanism of this increase is thought to be due primarily to Na ϩ -K ϩ -ATPase inhibition by the glycosides, which raises intracellular sodium (Na i ϩ ) causing a net influx of Ca 2ϩ via Na ϩ /Ca ϩ exchange (31) , thus increasing the uptake and subsequent release of Ca 2ϩ by the sarcoplasmic reticulum (SR) (2, 3, 38) . This proposal also suggests that changes in concentrations of Na i ϩ and Ca i 2ϩ occur at the restricted subsarcolemmal space, thus eliminating the requirement for significant ion changes in the bulk cytosol. However, this scheme is not sufficient to explain all effects of cardiac glycosides, such as different agents producing different effects on action and resting potentials and on the relationship between inotropy and toxicity (5, 13, 37) . In fact, experimental evidence has suggested the possibility of additional, possibly intracellular, actions by cardiac glycosides (8, 9, 25, 26) . Isenberg (11) reported that intracellular injection of nanomolar concentrations of ouabain and digoxin produced positive inotropic effects in isolated bovine ventricular myocytes, even in the absence of Na ϩ or the presence of digoxin-specific antibodies outside the cell. Intracellular actions have been considered possible for many years, especially because cardiac glycosides are able to cross the salcolemma (4, 5, 8) and it has been shown that glycosides directly activate the cardiac SRcalcium release channel in nanomolar concentrations (22, 29, 32) . Therefore, the possibility exists that glycosides induce positive inotropy by acting at an intracellular site. In view of this possibility, we investigated the inotropic effects of ouabain under Na ϩ -free and, in some cases K ϩ -free conditions, to eliminate the participation of Na ϩ /Ca ϩ exchange and/or Na ϩ -K ϩ -ATPase activity.
MATERIALS AND METHODS
Electrophysiological and mechanical recordings. The discontinuous single electrode ("switch") voltage-clamp mode of the Axoclamp-2 amplifier (Axon Instruments; Foster City, CA) was used with 2-to 4-M⍀ glass micropipettes filled with pipette solution. Cell suspension was placed in an experimental chamber mounted on the stage of an inverted microscope (Nikon Diaphot TMD; Nikon Optical; Tokyo, Japan). The chamber was perfused (1-2 ml/min) with Na ϩ -free Tyrode solution heated with a peltier device to 36 Ϯ 1°C. Only rod-shaped, Ca 2ϩ -tolerant myocytes with visible cross-striations were studied. The visual image was recorded via a video camera attached to the side port of the microscope and displayed on a video monitor, and the cell image was aligned with the rasters of a video edge detector (Crescent Electronics; Salt Lake City, UT). Voltage clamp protocols were directed by pCLAMP6 software (Axon Instruments). The analog signals from cell shortening, transmembrane potential, fluo 4-AM fluorescence and current were digitized at 5 kHz and stored in pCLAMP6 files for later analysis.
In all experiments, data recording started 10 min after rupture of the membrane patch to allow equilibration between the cytoplasm and pipette solution. The standard voltage clamp protocol involved a test step from a holding potential of Ϫ70 to 0 mV for 10-20 ms (2 s interpulse interval). In some experiments, the pulse protocols combined a ramp from Ϫ70 to Ϫ40 mV with a step pulse from Ϫ40 to 0 mV. L-type Ca 2ϩ current (ICa) was recorded by a two-step protocol: a 300-ms step from Ϫ70 to Ϫ40 mV (to allow inactivation of I Na) was followed by ICa activation during a 300-ms pulse to 0 mV (0.2 Hz). Solution exchange in the experimental chamber was completed within 1 min. In some experiments, myocytes were loaded with 10 mol/l fluo 4-AM (Molecular Probes) for 30 min at room temperature. Fluorescence transients are presented relative to resting (diastolic) fluorescence immediately before depolarization (Ft/F0) with excitation at 485 nm and emission recorded at 520 nm.
Chemicals and solutions. Saxitoxin (STX) was purchased from Calbiochem (La Jolla, CA). Thapsigargin was purchased from Alomone Labs (Jerusalem, Israel). All other chemicals and pharmacological agents were obtained from Sigma (St. Louis, MO). Ouabain was dissolved in water stock solution (1 ϫ 10 Ϫ3 mol/l), which was added directly to the external solution. Thapsigargin was dissolved in dimethyl sulfoxide stock solution (1 ϫ 10 Ϫ3 mol/l). The sodium-free external solution consisted of (in mmol Data analysis. Data are presented as means Ϯ SE. Each type of experiment was performed on the number of cells indicated (n) in at least three animals. Data were compared using paired or unpaired Student's t-tests or one-way ANOVA with secondary comparisons made by using a Student-Newman-Keuls test. Differences between sample means were considered significant if P was Ͻ0.05, unless indicated otherwise.
RESULTS

Effects of ouabain in Na
ϩ -free conditions. The first series of experiments investigated the effects of ouabain on excitation-contraction (E-C) coupling in sodium-free conditions. Because the goal of these experiments was to examine the effects of ouabain independent of its actions on Na ϩ -K ϩ -ATPase inhibition, it was essential to demonstrate that E-C coupling could be activated during inhibition of Na ϩ /Ca ϩ exchange. Therefore, pipette and external solutions contained no Na ϩ . A low-frequency (0.5 Hz) step pulse to 0 mV for 10-20 ms from a holding potential of Ϫ70 mV was used to assess inotropy but without development of Ca i 2ϩ overload. External solution also contained a low concentration of CaCl 2 (0.5 mmol/l) for the same reason. The graph in the lower part of Fig. 1 shows the typical time course of ouabain effects on cell shortening in a cat ventricular myocyte. Contractions were fairly small and stable during the control period. Cell shortening began to increase after application of ouabain, with a peak positive inotropic effect occurring after ϳ3 min. There was no change in resting cell length throughout the experiment. Subsequent superfusion of thapsigargin abolished all cell shortening, demonstrating that SR Ca 2ϩ release is responsible for cell shortening un- der these conditions. Representative recordings above A-G in Fig. 1 show cell shortening at the time points indicated on the graph. Insets on the graph also show that ionic current at time points A (control), F (at peak inotropic effect), and G (during superfusion with thapsigargin) were virtually identical with a large inward Li ϩ current immediately after depolarization. Note there was no indication of any inward current associated with contractions either in control or during superfusion with ouabain as would be expected to occur with activation of inward Na ϩ /Ca ϩ exchange current after SR Ca 2ϩ release, confirming the absence of Na ϩ in the external solution. Figure 2 shows the concentration dependence of the ouabain effect on fractional shortening. There was ϳ50% increase in shortening in the cell exposed to 1 mol/l, ϳ300% increase with 3 mol/l, and ϳ700% increase at 10 mol/l. The summary data show significant positive inotropic effects at all three concentrations with a significantly greater effect when increasing ouabain concentration from 1 to 3 mol/l. A further increase to 10 mol/l tended to produce a further stimulation in shortening although the increase did not achieve statistical significance. Contractions were completely abolished after application of 5 mol/l thapsigargin. These results demonstrate that ouabain has a positive inotropic effect in Na ϩ -free conditions, and that contractions in both the absence and presence of ouabain were the result of SR Ca 2ϩ release.
Effects of ouabain on Ca i
2ϩ transients. The effects of ouabain on Ca i 2ϩ transients were also investigated. Figure 3A shows original fluorescence recordings using fluo 4-AM and cell shortening in control, during superfusion with 3 mol/l ouabain, and after the addition of thapsigargin. Ouabain increased the magnitude of the Ca i 2ϩ transient (Fig. 3, A and B) . In addition, ouabain increased the rate of activation of Ca i 2ϩ release (dF/dt). The rate of removal of Ca 2ϩ from the cytoplasm (ϪdF/ dt) was also increased by ouabain application, from 0.035 Ϯ 0.009 U/s in control to 0.066 Ϯ 0.010 in 3 mol/l ouabain (n ϭ 12, P Ͻ 0.05). There was also a positive inotropic effect coincident with the increase in transient magnitude that was subsequently abolished by thapsigargin (Fig. 3D ). The fact that thapsigargin (33) . We examined the effects of ouabain after Na ϩ channel block using two separate protocols. Figure 4A shows the effects of ouabain after block of Na ϩ channels with STX application. Figure 4A , top, shows an inward current before application of STX, which likely represents Li ϩ current through the open Na ϩ channels. Subsequent superfusion of 5 mol/l STX eliminated the rapid inward component completely, leaving only a small component of inward Ca 2ϩ current, which was unaffected by 3 mol/l ouabain but was blocked by 20 mol/l nifedipine in the maintained presence of STX. Superimposed recordings in Fig. 4A , bottom, show cell shortening in control, during superfusion of STX, STX plus ouabain, and during exposure to nifedipine from the same experiment. Ouabain still induced a positive inotropic effect during STX application in Na ϩ -free conditions, and all contraction was abolished by nifedipine.
When Na ϩ channels were inactivated by a ramp from Ϫ70 to Ϫ40 mV in the absence of STX (Fig. 4B,  top) , only I Ca was activated during the test pulse from Ϫ40 to 0 mV. Ouabain had little effect on I Ca despite a modest rundown in magnitude under these conditions. Fig. 4B , bottom, shows that the positive inotropic effects of ouabain were retained despite inactivation of Na ϩ channels. Subsequent application of nifedipine completely abolished the inward current and contraction (not shown). Figure 4C summarizes these results, showing a positive inotropic effect of ouabain in the presence of STX, which is abolished by nifedipine and a similar positive inotropic action at holding potential of Ϫ40 mV. These results indicate that 1) the positive inotropic effects of ouabain in Na ϩ -free conditions do not require functional Na ϩ channels, and 2) Ca 2ϩ current activates contraction both before and during exposure to ouabain under these experimental conditions.
Because of its critical role in activating contraction, we also examined the effects of I Ca in the positive inotropic effect of ouabain. The original current recordings and summarized data in Fig. 5 show that ouabain (10 mol/l) had no effect on I Ca activated during depolarization from Ϫ40 to 0 mV in Na Figure 6 shows the effects of ouabain in NMDG-replaced, Na ϩ -free Tyrode's solution. Ouabain produced a positive inotropic effect in NMDG-replaced solution and, as in the previous experiments, all contraction was abolished by thapsigargin. Figure 7 shows the effects of ouabain in K ϩ -and Na ϩ -free (NMDG) solution. Fig. 7A shows an original recording of cell shortening. Changing the external solution from K ϩ -containing control (NMDG) to K ϩ -free (to inhibit Na ϩ -K ϩ -ATPase) did not by itself alter contractility (Fig. 7B) . Even in Na ϩ -and K ϩ -free conditions, ouabain (3 mol/l) still enhanced contractility. The inotropic effect was reduced after 3 min washout of ouabain (Fig. 7C ). These results demonstrate that the positive inotropic effects of ouabain are maintained even in the absence of functional Na ϩ /Ca ϩ exchange and Na ϩ -K ϩ -ATPase. Effects of ouabain on rat ventricular myocytes. It is well known that adult rat heart is relatively insensitive to glycosides compared with "sensitive" species, including guinea pig, cat, dog, and human (15) . Consequently, we investigated the glycoside sensitivity of rat ventricular myocytes in Na ϩ -free conditions. Figure 8A shows the effects of ouabain on Ca i 2ϩ -transients and contractions in rat ventricular myocytes. There was no change in either the transient or in cell shortening during exposure to ouabain (10 M). As summarized in Fig. 8 , B and C, exposure to high concentrations of ouabain (10 and 100 mol/l) had no effect on Ca i 2ϩ -transients or contraction. These results indicate that the inotropic effect of ouabain shows typical species dependencies, including a low sensitivity in the rat and high sensitivity in the cat. 
Ouabain reversibly exacerbates Ca 2ϩ -overload toxicity under Na
ϩ -free conditions. Many cat myocytes demonstrated Ca i 2ϩ -overload toxicity in the form of spontaneous aftercontractions in control (K ϩ -free, NMDG solution). We examined the effects of ouabain on such Ca i 2ϩ -overloaded cells. Figure 9A shows recordings of contraction evoked after the test depolarization, followed by an aftercontraction. During superfusion with ouabain, the cycle length between the primary contraction and the first aftercontraction decreased and two additional aftercontractions were activated. This enhancement of toxicity was reversed after 4 min of washout. The summary data in Fig. 9B show that the cycle length of the first aftercontraction was reduced by ouabain and that this effect was reversible after removal of glycoside. The same effect to shorten aftercontraction cycle length was obtained in 5.4 mmol/l-K ϩ NMDG conditions (Fig. 9C ). These results demonstrate that ouabain is capable of increasing toxicity resulting from Ca i 2ϩ -overload toxicity in the form of spontaneous aftercontractions even in the absence of active Na ϩ / Ca ϩ exchange or Na
DISCUSSION
Basis for the inotropic and toxic actions of cardiac glycosides. The "Na ϩ pump lag" theory states that cardiac glycosides bind specifically to and inhibit the sarcolemmal Na ϩ -K ϩ -ATPase, causing an accumulation of Na i ϩ , which increases free Ca i 2ϩ concentration ([Ca 2ϩ ] i ) via Na ϩ /Ca ϩ exchange (17) . Increased SR Ca 2ϩ uptake is responsible for the positive inotropic (therapeutic) action. The toxic (arrhythmogenic) effects occur when cytoplasmic Ca 2ϩ increases to a level exceeding SR storage capacity (14, 20) . In Ca i 2ϩ overload, SR function is compromised such that several oscillations of the release-reuptake cycle (aftercontractions) are required to establish a new Ca 2ϩ equilibrium between cytoplasm and SR.
A singular action via Na ϩ -K ϩ -ATPase inhibition and activation of Na ϩ /Ca ϩ exchange precludes the possibility that different glycosides might possess different cellular actions and toxic/therapeutic ratios, because it requires a fixed relationship among Na i ϩ concentration ([Na ϩ ] i ), [Ca 2ϩ ] i , inotropy, and toxicity. However, profound differences are known to exist among agents in toxic/therapeutic ratios in vivo (1, 24) and in action potential configuration in vitro (10, 12, 13, 34, 36, 37) . These results are difficult to reconcile with a single site and mechanism of action in the heart.
With the advent of newer, more powerful measuring techniques, evidence continues to accumulate that the positive inotropic effects of ouabain can be separated from changes in internal [Na 2ϩ ]. For example, Radford et al. (28) recently found no change in [Na ϩ ] i , as measured using 23 Na-labeled NMR, during the development of positive inotropy in intact guinea pig heart. These results continue to add to the body of evidence suggesting that other drug effects might contribute to the cellular actions in isolated tissues, intact organ, and whole animal.
We found that positive inotropic effects of ouabain persisted when Na ϩ /Ca ϩ exchange was inhibited in the absence of Na ϩ . Because there was a possibility that Li ϩ could substitute for Na ϩ and promote reverse exchange under our experimental conditions, we substituted a large organic monovalent cation, NMDG, and found that the positive inotropic effect of ouabain was retained. These results demonstrate that the inotropic action does not require involvement of the Na ϩ /Ca ϩ exchanger. We then inhibited the Na ϩ -K ϩ -ATPase directly by using K ϩ -free external solution and still the stimulatory effects of ouabain were observed. This was an important demonstration of two principles. First, pump inhibition itself failed to produce inotropy, showing that this action of glycoside was not sufficient to increase force in and of itself. Second, the inotropic effect of ouabain did not require a functional Na ϩ pump, thus precluding the possibility that the pump might act as a transport mechanism to bring glycoside to an intracellular site of action (9, 26) . Interestingly, the same conditions (K ϩ -free, NMDG solutions) were used in the demonstration of enhanced toxicity by ouabain in Ca 2ϩ -overloaded myocytes, suggesting that the toxic and inotropic actions might in fact share a common mechanism separate from, and in addition to, Na ϩ pump inhibition.
A recent report has also underscored the important contribution of pump inhibition and the role of the Na ϩ /Ca ϩ exchanger in the development of inotropy in embryonic heart tubes from exchanger knockout mice (30) . Under these conditions, heart tubes from wildtype animals gave a normal positive inotropic response to ouabain, whereas those from the knockout mice did not. These results provide strong evidence for the Na ϩ -lag hypothesis and the role of the exchanger. However, the details of E-C coupling (e.g., relative contributions of ryanodine receptors and SR Ca 2ϩ release compared with Ca 2ϩ influx via I Ca ) are not well understood in this model, nor is the sensitivity of mouse ryanodine receptors to glycoside. It will be very interesting to determine whether other mechanisms contribute to the inotropic and/or toxic actions of glycosides in the presence and the absence of the Na ϩ /Ca ϩ exchanger. Alternative actions of cardiac glycosides. One of the possible alternative actions considered in these experiments was that Ca 2ϩ influx via Na ϩ channels could contribute to inotropic effects of ouabain (33) . We found that both pharmacological blockade and voltage-dependent inactivation of I Na failed to abolish the inotropic effects of ouabain. In fact, we found that contraction was completely abolished when I Ca was blocked by nifedipine. Thus it seems unlikely that slip-mode conductance contributes to inotropic effects of ouabain under our experimental conditions.
We also investigated the possibility that alterations in I Ca might contribute to inotropy (16, 19) . However, under our conditions, I Ca was unchanged despite the development of positive inotropy. In addition, all contractions were abolished by thapsigargin, demonstrating that basal contractions and the positive inotropic stimulation induced by ouabain were the result of normal E-C coupling mechanisms involving Ca 2ϩ influx via L-type Ca 2ϩ channels causing release of Ca 2ϩ from the SR. Thus the effects of ouabain do not appear to include actions on I Ca or to alter the normal means of Ca 2ϩ influx. With accumulating evidence that other cellular actions might be involved in digitalis effects in the heart, several reports have suggested the possibility of an intracellular action for glycosides. This is not such an unlikely prospect given the fact that different glycosides (including ouabain) cross the sarcolemma and accumulate in the SR (5) . One of the most convincing demonstrations of an intracellular action used pressure injection of ouabain and digoxin into isolated bovine ventricular cells, which resulted in increased contraction, even in the absence of external Na ϩ and in the presence of extracellular digoxin Fab antibodies, which excluded an action on the Na ϩ -K ϩ -ATPase (11). Nunez-Duran et al. (25) subsequently reported that inhibition of uptake of a glycoside-receptor complex in guinea pig atria prevented inotropic effects of the nonpolar compound ouabain, whereas the normal inotropic response occurred with a lipophilic agent (ouabagenin), suggesting an intracellular action of certain cardiac steroids.
One potential locus of intracellular action was suggested by the specific binding of glycosides to SR fractions (5) and increased 45 Ca 2ϩ release from cardiac SR by ouabain (9) . Little was subsequently published about this interesting possibility until we reported a direct SR action by several glycosides to increase single-channel open probability (P o ) of canine crude cardiac SR Ca 2ϩ release channels inserted into artificial lipid bilayers (29) . Subsequent reports (22, 23) confirmed that digoxin (1-3 nmol/l) increased P o by increasing the number of openings but did not increase open time except at high drug concentrations (30-100 nmol/l). Thus only 1% or less of the glycoside needs to cross the sarcolemma, which is easily accomplished by lipophillic agents (digoxin) but is also likely to occur with more hydrophilic agents like ouabain with an octanol/water partition coefficient of 0.01 (4). Skeletal channel activity was unaffected by even micromolar concentrations. These authors subsequently reported direct [ 3 H]digoxin binding to SR vesicles, with both high [dissociation constant (K d ) ϭ 10 nmol/l] and low (K d ϭ 3.5 mol/l) affinity binding (22) . In addition to a contribution to positive inotropy, the agent R-56865 not only blocked digoxin binding to the channel but also abolished arrhythmias in intact hearts, suggesting a toxic consequence of interaction of digoxin with a binding site on the channel.
Other possible mechanisms might be involved in the actions of glycosides. Increased sensitivity of the contractile myofilaments might play a role in inotropy, especially because there was a dramatic increase in cell shortening compared with the modest increase in Ca i 2ϩ -transient magnitude. This effect is normally associated with a slowing in the rate of relaxation of the transients but was not observed under these experimental conditions. In fact, there was evidence of an acceleration of relaxation rate, possibly suggesting a lack of effect of ouabain on myofilament sensitivity. Another possible action of ouabain is suggested by this acceleration of relaxation of the transients, namely, an increase in Ca 2ϩ uptake rate into the SR. The increase in uptake could be responsible for increased Ca 2ϩ available for release, thus increasing cell shortening. This possibility remains to be explored by direct measurements of changes in isolated SR Ca-ATPase activity in the presence of glycoside. Finally, it is possible that pump inhibition by ouabain might activate tyrosine kinase with secondary activation of the MAPK system, which has been suggested to contribute to a positive inotropic effect in cultured neonatal rat myocytes (18, 27) . It is not yet known, however, if this system is activated in adult cardiac myocytes and if this mechanism might contribute to the positive inotropic effects in 0 Na ϩ solutions described in this study. Possible involvement of additional inotropic mechanisms is also important because it is unlikely that simply increasing SR Ca 2ϩ release alone can result in a sustained positive inotropic effect. This point has been considered in some detail, because an intervention that only alters SR Ca 2ϩ release will cause a transient change in contraction as SR Ca 2ϩ stores achieve a new equilibrium within a few beats (7, 35 ). These investigators demonstrate that it is necessary to invoke additional mechanisms to develop a sustained inotropic change. It is therefore entirely possible that other cellular actions of glycosides may be involved in addition to effects on the Na ϩ pump and cardiac ryanodine receptors, possibly resulting in the observed acceleration of relaxation of the Ca 2ϩ transient and increased SR Ca 2ϩ uptake. Species sensitivities of ouabain actions. One of the characteristics of glycoside actions is the well-known reduced sensitivity in rat heart compared with most other mammalian species (15) . This difference has been ascribed to the fact that the glycoside-sensitive ␣ 3 -isoform of the Na ϩ -K ϩ -ATPase is largely replaced by the insensitive ␣ 1 -isoform in adult rat heart (21). We found that rat myocytes were insensitive to ouabain at concentrations Յ100 mol/l in Na ϩ -free solutions. This finding suggests that the mechanism responsible for inotropy in Na ϩ -free solutions is absent in rat heart. We have recently reported that rat cardiac SR Ca 2ϩ release channels is activated only at extremely high concentrations of digoxin (ϳ1 mol/l) but that dog and human channels are activated at nanomolar concentrations (32). These observations provide additional evidence that activation of the channel may be involved in the cellular actions of glycosides in sensitive species (cat, human, dog, etc.) but does not play a role in the responses of rat heart to glycoside.
